Non-Neutropenic Sepsis in Cancer Patients: The Luminal Obstruction Syndrome - Journal of Cancer Therapy

JCT > Vol.10 No.10, October 2019

Non-Neutropenic Sepsis in Cancer Patients: The Luminal Obstruction Syndrome ()

HTML XML

Download as PDF (Size: 1030KB) PP. 789-795

DOI: 10.4236/jct.2019.1010066 914 Downloads 3,159 Views

Author(s)

Tamás Kullmann^*, Dóra Füzi, Tamás Pintér

Affiliation(s)

Department of Oncoradiology, Petz Aladár Hospital, Gyor, Hungary.

ABSTRACT

Background: Neutropenic sepsis is a frequent complication of cytotoxic chemotherapy delivered for cancer patients. Its management is well determined by clinical guidelines. Non-neutropenic sepsis is another potential complication in cancer patients. Its management is less established in the medical literature. Materials and Methods: Three cases are presented to illustrate favourable evolution of non-neutropenic biliary-, uro- and bronchogenic-sepsis in cancer patients with poor prognosis. Results: All three patients had a survival over six months after the management of the septic complication. Two of them received subsequent systemic anticancer treatment. Conclusions: Survival benefit offered by the management of cancer-related non-neutropenic sepsis may be comparable to the benefit obtained by systemic anticancer treatments. Cost-effectiveness of sepsis management may be better than that of anticancer treatments.

KEYWORDS

Sepsis, Biliary Sepsis, Urosepsis, Bronchogenic Sepsis, Solid Cancer

Share and Cite:

Kullmann, T. , Füzi, D. and Pintér, T. (2019) Non-Neutropenic Sepsis in Cancer Patients: The Luminal Obstruction Syndrome. Journal of Cancer Therapy, 10, 789-795. doi: 10.4236/jct.2019.1010066.

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies